Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStojic, Isidora-
dc.contributor.authorZivkovic V.-
dc.contributor.authorSrejovic I.-
dc.contributor.authorJeremić N.-
dc.contributor.authorJakovljevic V.-
dc.contributor.authorDjuric D.-
dc.contributor.authorNovokmet, Slobodan-
dc.description.abstract© 2016, University of Kragujevac, Faculty of Science. All Rights Reserved. To date, numerous platinum (II) complexes have been successfully used in the treatment of different types of cancer. Therapeutic platinum complexes are different in terms of their structure, chemical reactivity, solubility, pharmacokinetics and toxicity. The aim of our research was the evaluation of cardiotoxicity of dichloro-(ethylendiamine) platinum (II) in a model of isolated rat heart using the Langedorff technique. Oxidative stress was assessed by determination of superoxide anion radical, hydrogen peroxide, Thiobarbituric Acid Reactive Substances and nitric oxide levels from coronary venous effluent. All reagents were perfused at increasing concentrations from 10-8 to 10-4M for 30 minutes. In this paper, we report that substances administered at higher doses did not induce dose-dependent effects on oxidative stress markers. The results of this research may be of great interest for future studies in this area. Theere are many novel platinum compounds that had previously demonstrated antitumour activity, and these types of experiments in our study can assist in the examination of their cardiotoxicity. Theese results could be helpful for understanding dose-dependent side effects of existing and novel platinum compounds.-
dc.sourceSerbian Journal of Experimental and Clinical Research-
dc.titleThe effects of cisplatin and its Pt (II) analogue on oxidative stress of isolated rat heart-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)




Files in This Item:
File Description SizeFormat 
10.1515-SJECR-2015-0050.pdf157.05 kBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons